Status:
COMPLETED
Non-small Cell Lung Cancer Study US75 (Z-PACT)
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Non Small Cell Lung Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this ...
Eligibility Criteria
Inclusion
- Male or Female patients at least of 18 years old
- Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
- Women must not be pregnant or attempting to become pregnant
- Able and willing to sign informed consent
Exclusion
- Patients with cancer that has spread to the bone
- Patients with cancer that has spread to the brain who are receiving treatment
- Patients with kidney disease
- Patients treated with other investigational drugs
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00086268
Start Date
April 1 2004
End Date
October 1 2007
Last Update
September 13 2017
Active Locations (80)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Consultants
Hoover, Alabama, United States, 35216
2
Arizona Oncology Assoc.
Tucson, Arizona, United States, 85715
3
NEA Clinic
Jonesboro, Arkansas, United States, 72401
4
Highlands Oncology Group
Springdale, Arkansas, United States, 72764